NCT00001416View on ClinicalTrials.gov

Bone Response to Enzyme Replacement in Gaucher's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 1993

Study Completion Date

November 30, 2000

Conditions

Gaucher's Disease

Interventions

DRUG

CEREDASE™

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH